This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Whittier, S Articles by Gilligan, P H Search for Related Content PubMed PubMed Citation Articles by Whittier, S Articles by Gilligan, P H

Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis.

Clinical Microbiology Immunology Laboratories, University of North Carolina Hospitals, Chapel Hill.

ABSTRACT

Pulmonary colonization and infection of patients with cystic fibrosis by Mycobacterium spp. has recently been recognized as a potentially important clinical problem. However, frequent contamination of mycobacterial cultures by pseudomonads has hampered efforts to define the extent of this problem. This study was done to evaluate current techniques and to establish a more efficient method of recovering mycobacteria from respiratory secretions of patients with cystic fibrosis. Decontamination of respiratory specimens (n = 121) with 0.25% N-acetyl-L-cysteine and 1% sodium hydroxide (NALC-NaOH) was associated with a high rate of pseudomonas overgrowth for both Lowenstein-Jensen slants (74%) and BacTec vials supplemented with PANTA (polymyxin B [50 U/ml], amphotericin B [5 micrograms/ml], nalidixic acid [20 micrograms/ml], trimethoprim [5 micrograms/ml], azlocillin [10 micrograms/ml]) (36%). This overgrowth limited recovery of mycobacteria to only 64% (9 of 14) of specimens positive by smear for acid-fast bacilli (AFB). Decontamination of specimens (n = 441) with NALC-NaOH, followed by 5% oxalic acid treatment, resulted in contamination of only 5% of Lowenstein-Jensen slants and 3% of BacTec vials. AFB were recovered from all 90 AFB smear-positive specimens following the use of this decontamination technique. We recommend that respiratory secretions be decontaminated with NALC-NaOH and oxalic acid to decrease the incidence of Pseudomonas aeruginosa overgrowth.

This article has been cited by other articles:

• Jonsson, B. E., Gilljam, M., Lindblad, A., Ridell, M., Wold, A. E., Welinder-Olsson, C. (2007). Molecular Epidemiology of Mycobacterium abscessus, with Focus on Cystic Fibrosis. J. Clin. Microbiol. 45: 1497-1504 [Abstract] [Full Text]  
• Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., Iseman, M., Olivier, K., Ruoss, S., von Reyn, C. F., Wallace, R. J. Jr., Winthrop, K., on behalf of the ATS Mycobacterial Diseases Subcom, (2007). An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. Am. J. Respir. Crit. Care Med. 175: 367-416 [Full Text]  
• Ferroni, A., Vu-Thien, H., Lanotte, P., Le Bourgeois, M., Sermet-Gaudelus, I., Fauroux, B., Marchand, S., Varaigne, F., Berche, P., Gaillard, J.-L., Offredo, C. (2006). Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis.. J. Clin. Microbiol. 44: 2237-2239 [Abstract] [Full Text]  
• Chalermskulrat, W, Sood, N, Neuringer, I P, Hecker, T M, Chang, L, Rivera, M P, Paradowski, L J, Aris, R M (2006). Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax 61: 507-513 [Abstract] [Full Text]  
• Pierre-Audigier, C., Ferroni, A., Sermet-Gaudelus, I., Le Bourgeois, M., Offredo, C., Vu-Thien, H., Fauroux, B., Mariani, P., Munck, A., Bingen, E., Guillemot, D., Quesne, G., Vincent, V., Berche, P., Gaillard, J.-L. (2005). Age-Related Prevalence and Distribution of Nontuberculous Mycobacterial Species among Patients with Cystic Fibrosis. J. Clin. Microbiol. 43: 3467-3470 [Abstract] [Full Text]  
• Gibson, R. L., Burns, J. L., Ramsey, B. W. (2003). Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis. Am. J. Respir. Crit. Care Med. 168: 918-951 [Abstract] [Full Text]  
• Saiman, L., Marshall, B. C., Mayer-Hamblett, N., Burns, J. L., Quittner, A. L., Cibene, D. A., Coquillette, S., Fieberg, A. Y., Accurso, F. J., Campbell, P. W. III (2003). Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa: A Randomized Controlled Trial. JAMA 290: 1749-1756 [Abstract] [Full Text]  
• Miller, M. B., Gilligan, P. H. (2003). Laboratory Aspects of Management of Chronic Pulmonary Infections in Patients with Cystic Fibrosis. J. Clin. Microbiol. 41: 4009-4015 [Full Text]  
• Olivier, K. N., Weber, D. J., Wallace, R. J. Jr., Faiz, A. R., Lee, J.-H., Zhang, Y., Brown-Elliot, B. A., Handler, A., Wilson, R. W., Schechter, M. S., Edwards, L. J., Chakraborti, S., Knowles, M. R. (2003). Nontuberculous Mycobacteria: I: Multicenter Prevalence Study in Cystic Fibrosis. Am. J. Respir. Crit. Care Med. 167: 828-834 [Abstract] [Full Text]  
• Olivier, K. N., Weber, D. J., Lee, J.-H., Handler, A., Tudor, G., Molina, P. L., Tomashefski, J., Knowles, M. R. (2003). Nontuberculous Mycobacteria: II: Nested-Cohort Study of Impact on Cystic Fibrosis Lung Disease. Am. J. Respir. Crit. Care Med. 167: 835-840 [Abstract] [Full Text]  
• Bange, F.-C., Kirschner, P., Böttger, E. C. (1999). Recovery of Mycobacteria from Patients with Cystic Fibrosis. J. Clin. Microbiol. 37: 3761-3763 [Abstract] [Full Text]  
• Shreve, M. R., Butler, S., Kaplowitz, H. J., Rabin, H. R., Stokes, D., Light, M., Regelmann, W. E., Investigators for the Epidemiologic Study of Cysti, (1999). Impact of Microbiology Practice on Cumulative Prevalence of Respiratory Tract Bacteria in Patients with Cystic Fibrosis. J. Clin. Microbiol. 37: 753-757 [Abstract] [Full Text]  
• Palomino, J. C., Portaels, F. (1998). Effects of Decontamination Methods and Culture Conditions on Viability of Mycobacterium ulcerans in the BACTEC System. J. Clin. Microbiol. 36: 402-408 [Abstract] [Full Text]  
• (1997). Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria. Am. J. Respir. Crit. Care Med. 156: 1-25 [Full Text]